Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

Date: May 15, 2012
Pages: 103
Price:
US$ 2,500.00 US$ 2,250.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GAEC3FEB3A6EN
Leaflet:

Download PDF Leaflet

Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

”Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Greece Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope
  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the six market categories.
  • Global corporate-level profiles of key companies operating within the Greece Neurology Devicesmarket.
  • Key players covered include Medtronic, Inc., Stryker Corporation, St. Jude Medical, Inc., DePuy, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc. and others.

Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Greece Neurology Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 NEUROLOGY DEVICES IN GREECE

3.1 Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Neurology Devices, Greece, Company Share (2010-2011)

4 CSF MANAGEMENT IN GREECE

4.1 CSF Management Overall Revenue, (2004-2018)
4.2 CSF Management Overall Volume (2004-2018)
4.3 CSF Management Average Price (2004-2018)
4.4 CSF Management Distribution Share (2010-2011)
4.5 CSF Management, Greece, Company Share (2010-2011)

5 INTERVENTIONAL NEUROLOGY IN GREECE

5.1 Interventional Neurology Overall Revenue, (2004-2018)
  5.1.1 Embolic Systems Revenue (2004-2018)
  5.1.2 Navigational Systems Revenue (2004-2018)
5.2 Interventional Neurology Overall Volume (2004-2018)
  5.2.1 Embolic Systems Volume (2004-2018)
  5.2.2 Navigational Systems Volume (2004-2018)
5.3 Interventional Neurology Average Price (2004-2018)
5.4 Interventional Neurology Distribution Share (2010-2011)
5.5 Interventional Neurology, Greece, Company Share (2010-2011)

6 NEUROLOGICAL DIAGNOSTIC EQUIPMENT IN GREECE

6.1 Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
6.2 Neurological Diagnostic Equipment Overall Volume (2004-2018)
6.3 Neurological Diagnostic Equipment Average Price (2004-2018)
6.4 Neurological Diagnostic Equipment Distribution Share (2010-2011)
6.5 Neurological Diagnostic Equipment, Greece, Company Share (2010-2011)

7 NEUROSTIMULATION DEVICES IN GREECE

7.1 Neurostimulation Devices Overall Revenue, (2004-2018)
7.2 Neurostimulation Devices Overall Volume (2004-2018)
7.3 Neurostimulation Devices Average Price (2004-2018)
7.4 Neurostimulation Devices Distribution Share (2010-2011)
7.5 Neurostimulation Devices, Greece, Company Share (2010-2011)

8 NEUROSURGICAL PRODUCTS IN GREECE

8.1 Neurosurgical Products Overall Revenue, (2004-2018)
8.2 Neurosurgical Products Overall Volume (2004-2018)
8.3 Neurosurgical Products Average Price (2004-2018)
8.4 Neurosurgical Products Distribution Share (2010-2011)
8.5 Neurosurgical Products, Greece, Company Share (2010-2011)

9 RADIOSURGERY IN GREECE

9.1 Radiosurgery Overall Revenue, (2004-2011)
9.2 Radiosurgery Overall Volume (2004-2011)
9.3 Radiosurgery Average Price (2004-2011)

10 OVERVIEW OF KEY COMPANIES IN GREECE NEUROLOGY DEVICES MARKET

10.1 Medtronic, Inc.
  10.1.1 Company Overview
10.2 Boston Scientific Corporation
  10.2.1 Company Overview
10.3 St. Jude Medical, Inc.
  10.3.1 Company Overview
10.4 B. Braun Melsungen AG
  10.4.1 Company Overview
10.5 Cadwell Laboratories, Inc.
  10.5.1 Company Overview
10.6 Natus Medical Incorporated
  10.6.1 Company Overview
10.7 DePuy, Inc.
  10.7.1 Company Overview
10.8 Terumo Corporation
  10.8.1 Company Overview
10.9 CareFusion Corporation
  10.9.1 Company Overview
10.10 Integra LifeSciences Holdings Corporation
  10.10.1 Company Overview
10.11 Micromed S.p.A
  10.11.1 Company Overview
10.12 Nihon Kohden Corporation
  10.12.1 Company Overview
10.13 Cyberonics, Inc.
  10.13.1 Company Overview
10.14 Christoph Miethke GmbH & Co. KG
  10.14.1 Company Overview
10.15 KARL STORZ GmbH & Co. KG
  10.15.1 Company Overview
10.16 Stryker Corporation
  10.16.1 Company Overview
10.17 Sophysa S.A.
  10.17.1 Company Overview
10.18 Covidien plc
  10.18.1 Company Overview

11 APPENDIX

11.1 Global Markets Direct Research Methodology
11.2 Definitions of Markets Covered in the Report
  11.2.1 Neurology Devices
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panel Validation
11.8 Currency Conversion
11.9 Contact Us
11.10 Disclaimer

LIST OF TABLES

Table 1: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Neurology Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 5: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 6: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 7: CSF Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 8: CSF Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Table 9: CSF Management, Greece, Average Price ($), Historic, 2004-2011
Table 10: CSF Management, Greece, Average Price ($), Forecast, 2011-2018
Table 11: CSF Management, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: CSF Management, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 14: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 15: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 16: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 17: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 18: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 19: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 20: Interventional Neurology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Table 21: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 22: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 23: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 24: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 25: Interventional Neurology, Greece, Average Price ($), Historic, 2004-2011
Table 26: Interventional Neurology, Greece, Average Price ($), Forecast, 2011-2018
Table 27: Interventional Neurology, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 28: Interventional Neurology, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 30: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 31: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 32: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Table 33: Neurological Diagnostic Equipment, Greece, Average Price ($), Historic, 2004-2011
Table 34: Neurological Diagnostic Equipment, Greece, Average Price ($), Forecast, 2011-2018
Table 35: Neurological Diagnostic Equipment, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Neurological Diagnostic Equipment, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 38: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 39: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 40: Neurostimulation Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Table 41: Neurostimulation Devices, Greece, Average Price ($), Historic, 2004-2011
Table 42: Neurostimulation Devices, Greece, Average Price ($), Forecast, 2011-2018
Table 43: Neurostimulation Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 44: Neurostimulation Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 45: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 46: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 47: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 48: Neurosurgical Products, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Table 49: Neurosurgical Products, Greece, Average Price ($), Historic, 2004-2011
Table 50: Neurosurgical Products, Greece, Average Price ($), Forecast, 2011-2018
Table 51: Neurosurgical Products, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Neurosurgical Products, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 53: Radiosurgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 54: Radiosurgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
Table 55: Radiosurgery, Greece, Average Price ($), Historic, 2004-2011

LIST OF FIGURES

Figure 1: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Neurology Devices, Greece, Company Share (%), 2011
Figure 5: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 6: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 7: CSF Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 8: CSF Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Figure 9: CSF Management, Greece, Company Share (%), 2011
Figure 10: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 11: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 12: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 13: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 14: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 17: Interventional Neurology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Figure 18: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 19: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 20: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 21: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 22: Interventional Neurology, Greece, Company Share (%), 2011
Figure 23: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 24: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 25: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 26: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Figure 27: Neurological Diagnostic Equipment, Greece, Company Share (%), 2011
Figure 28: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 31: Neurostimulation Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Figure 32: Neurostimulation Devices, Greece, Company Share (%), 2011
Figure 33: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 34: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 35: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 36: Neurosurgical Products, Greece, Volume (Units) by Segment, Forecast, 2011-2018
Figure 37: Neurosurgical Products, Greece, Company Share (%), 2011
Figure 38: Radiosurgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 39: Radiosurgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
Figure 40: Global Markets Direct Methodology

COMPANIES MENTIONED

Medtronic, Inc.
Boston Scientific Corporation
St. Jude Medical, Inc.
B. Braun Melsungen AG
Cadwell Laboratories, Inc.
Natus Medical Incorporated
DePuy, Inc.
Terumo Corporation
CareFusion Corporation
Integra LifeSciences Holdings Corporation
Micromed S.p.A
Nihon Kohden Corporation
Cyberonics, Inc.
Christoph Miethke GmbH & Co. KG
KARL STORZ GmbH & Co. KG
Stryker Corporation
Sophysa S.A.
Covidien plc

Ask Your Question

Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: